Additionally, miR-155 can promote tumor invasion and metastasis in breast cancer by downregulating its target, RhoA [31] and promote tumor invasion and metastasis in pancreas duct carcinoma by repressing the expression of TP53INP1 [32]. This evidence concerns the gene RHOA and neoplasm.